Literature DB >> 26282646

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?

Matthew B Yurgelun1, Elaine Hiller2, Judy E Garber3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26282646     DOI： 10.1200/JCO.2015.60.8596

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

Review 1.  Population genetic testing for cancer susceptibility: founder mutations to genomes.

Authors:  William D Foulkes; Bartha Maria Knoppers; Clare Turnbull
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

Review 2.  Ovarian Cancer Prevention in High-risk Women.

Authors:  Sarah M Temkin; Jennifer Bergstrom; Goli Samimi; Lori Minasian
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

3.  The future of clinical cancer genomics.

Authors:  Kenneth Offit
Journal:  Semin Oncol       Date:  2016-10-18       Impact factor: 4.929

4.  Quantifying risk stratification provided by diagnostic tests and risk predictions: Comparison to AUC and decision curve analysis.

Authors:  Hormuzd A Katki
Journal:  Stat Med       Date:  2019-04-30       Impact factor: 2.373

5.  A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2.

Authors:  Ana F Best; Margaret A Tucker; Megan N Frone; Mark H Greene; June A Peters; Hormuzd A Katki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-28       Impact factor: 4.254

6.  Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time.

Authors:  Filipa Lynce; Claudine Isaacs
Journal:  J Natl Compr Canc Netw       Date:  2016-06       Impact factor: 11.908

7.  Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.

Authors:  Sari Lieberman; Amnon Lahad; Ariela Tomer; Carmit Cohen; Ephrat Levy-Lahad; Aviad Raz
Journal:  Genet Med       Date:  2016-12-01       Impact factor: 8.822

8.  Comprehension and personal value of negative non-diagnostic genetic panel testing.

Authors:  Christin Hoell; Sharon Aufox; Nora Nashawaty; Melanie F Myers; Maureen E Smith
Journal:  J Genet Couns       Date:  2020-09-18       Impact factor: 2.537

9.  Examining the uptake of predictive BRCA testing in the UK; findings and implications.

Authors:  Karen Lynn Greenhalgh; Munir Pirmohamed; Antony P Martin; Jennifer Downing; Brendan Collins; Brian Godman; Ana Alfirevic
Journal:  Eur J Hum Genet       Date:  2020-12-16       Impact factor: 4.246

10.  Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!

Authors:  Hikmat Abdel-Razeq
Journal:  Oncol Rev       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.